Ergoteles’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-21,344
Closed -$3.95M 198
2023
Q2
$3.95M Buy
21,344
+16,113
+308% +$2.98M 0.19% 131
2023
Q1
$1M Sell
5,231
-249
-5% -$45K 0.04% 500
2022
Q4
$922K Sell
5,480
-5,217
-49% -$907K 0.03% 487
2022
Q3
$1.9M Buy
10,697
+246
+2% +$48.6K 0.07% 294
2022
Q2
$2.14M Buy
10,451
+7,197
+221% +$1.53M 0.06% 299
2022
Q1
$774K Buy
3,254
+1,709
+111% +$401K 0.03% 514
2021
Q4
$353K Buy
+1,545
New +$340K 0.01% 787
2021
Q1
Sell
-8,947
Closed -$1.63M 828
2020
Q4
$1.63M Buy
+8,947
New +$1.52M 0.05% 270

Other funds holding CME

Ergoteles's CME Position: Q3 2023 in Review

Ergoteles sold out of CME Group (CME) in Q3 2023, closing a stake of 21,344 shares — an estimated $3.95M sold.

Ergoteles first reported a position in CME in Q4 2020 and held it in 8 quarters. The position peaked at $3.95M in Q2 2023. 1,229 funds tracked by Wall St. Rank hold CME as of Q3 2023.

  • Ergoteles reported no remaining CME Group position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 21,344 CME Group shares in Q3 2023, an estimated $3.95M.
  • Ergoteles first reported a position in CME Group in Q4 2020 and held it in 8 quarters.
  • Ergoteles's CME Group position peaked at $3.95M in Q2 2023.
  • 1,229 funds tracked by Wall St. Rank held CME Group as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.